• 1. Pediatric Department;Tongchuan Mining Bureau Central Hospital, Tongchuan, Shaanxi 727000, P. R. China;
  • 2. Department of General Surgery;Tongchuan Mining Bureau Central Hospital, Tongchuan, Shaanxi 727000, P. R. China;
Export PDF Favorites Scan Get Citation

Objective To investigate the efficacy of Orem's self-care model in school-age children with asthma. Methods Seventy-four children with asthma treated between March 2012 and June 2014 were divided into observation group (n=37) and control group (n=37) randomly. Orem's self-care model was applied in the observation group, while routine nursing was carried out in the control group. We observed the pulmonary function, therapeutic compliance and quality of life in children of both the two groups before and one year after treatment. Results One year after treatment, forced expiratory volume in one second and peak expiratory flow increased significantly (P<0.05), and increase in the observation group was significantly more than that in the control group (P<0.05). Compared with the control group, the observation group showed significant increased treatment compliance rate (P<0.05). Pediatric asthma quality of life questionare scale results showed that one year after treatment, the two groups got significantly increased scores in the dimensions of emotion, symptom and activity (P<0.05), and the scores were significantly higher in the observation group (P<0.05). Conclusion Orem's self-care model has a significant curative effect for the improvement of lung function in school-age children with asthma, which can promot the treatment compliance and quality of life of the patients.

Citation: ZhangXuejun, LiCongling, MengYaxi. Study on the Effect of Orem's Self-care Model in School-age Children with Asthma. West China Medical Journal, 2016, 31(9): 1585-1588. doi: 10.7507/1002-0179.201600433 Copy

  • Previous Article

    孕产妇第一产程状态焦虑与常模的对比性研究
  • Next Article

    Comparison of Application and Nursing between Continuous Hyperthermic Peritoneal Perfusion Chemotherapy and Intravenous Chemotherapy for Advanced Gastric Cancer Patients